Evidence map›Paper›PMID 34122841›Full record

ArticleChemical science2020

Unravelling the effect of

Laura Mariño, Rafael Ramis, Rodrigo Casasnovas, Joaquín Ortega-Castro, Bartolomé Vilanova, Juan Frau, Miquel Adrover

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Laura MariñoInstitut Universitari d'Investigació en Ciències de la Salut (IUNICS), Institut d'Investigació Sanitària Illes Balears (IdISBa), Departament de Química, Universitat de les Illes Balears Ctra. Valldemossa km 7.5 E-07122 Palma de Mallorca Spain miquel.adrover@uib.es +34 971 173426 +34 971 173491.ORCID https://orcid.org/0000-0003-1658-7179
Rafael RamisInstitut Universitari d'Investigació en Ciències de la Salut (IUNICS), Institut d'Investigació Sanitària Illes Balears (IdISBa), Departament de Química, Universitat de les Illes Balears Ctra. Valldemossa km 7.5 E-07122 Palma de Mallorca Spain miquel.adrover@uib.es +34 971 173426 +34 971 173491.ORCID https://orcid.org/0000-0002-4435-8990
Rodrigo CasasnovasInstitut Universitari d'Investigació en Ciències de la Salut (IUNICS), Institut d'Investigació Sanitària Illes Balears (IdISBa), Departament de Química, Universitat de les Illes Balears Ctra. Valldemossa km 7.5 E-07122 Palma de Mallorca Spain miquel.adrover@uib.es +34 971 173426 +34 971 173491.ORCID https://orcid.org/0000-0002-7102-1840
Joaquín Ortega-CastroInstitut Universitari d'Investigació en Ciències de la Salut (IUNICS), Institut d'Investigació Sanitària Illes Balears (IdISBa), Departament de Química, Universitat de les Illes Balears Ctra. Valldemossa km 7.5 E-07122 Palma de Mallorca Spain miquel.adrover@uib.es +34 971 173426 +34 971 173491.ORCID https://orcid.org/0000-0001-8131-0315
Bartolomé VilanovaInstitut Universitari d'Investigació en Ciències de la Salut (IUNICS), Institut d'Investigació Sanitària Illes Balears (IdISBa), Departament de Química, Universitat de les Illes Balears Ctra. Valldemossa km 7.5 E-07122 Palma de Mallorca Spain miquel.adrover@uib.es +34 971 173426 +34 971 173491.ORCID https://orcid.org/0000-0001-9464-9238
Juan FrauInstitut Universitari d'Investigació en Ciències de la Salut (IUNICS), Institut d'Investigació Sanitària Illes Balears (IdISBa), Departament de Química, Universitat de les Illes Balears Ctra. Valldemossa km 7.5 E-07122 Palma de Mallorca Spain miquel.adrover@uib.es +34 971 173426 +34 971 173491.ORCID https://orcid.org/0000-0003-2562-9975
Miquel AdroverInstitut Universitari d'Investigació en Ciències de la Salut (IUNICS), Institut d'Investigació Sanitària Illes Balears (IdISBa), Departament de Química, Universitat de les Illes Balears Ctra. Valldemossa km 7.5 E-07122 Palma de Mallorca Spain miquel.adrover@uib.es +34 971 173426 +34 971 173491.ORCID https://orcid.org/0000-0002-4211-9013
Health Research Institute of the Balearic Islands · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

α-Synuclein (αS) aggregation is a hallmark in several neurodegenerative diseases. Among them, Parkinson's disease is highlighted, characterized by the intraneuronal deposition of Lewy bodies (LBs) which causes the loss of dopaminergic neurons. αS is the main component of LBs and in them, it usually contains post-translational modifications. One of them is the formation of advanced glycation end-products (mainly CEL and MOLD) arising from its reaction with methylglyoxal. Despite its biological relevance, there are no data available proving the effect of glycation on the conformation of αS, nor on its aggregation mechanism. This has been hampered by the formation of a heterogeneous set of compounds that precluded conformational studies. To overcome this issue, we have here produced αS homogeneously glycated with CEL. Its use, together with different biophysical techniques and molecular dynamics simulations, allowed us to study for the first time the effect of glycation on the conformation of a protein. CEL extended the conformation of the N-terminal domain as a result of the loss of transient N-/C-terminal long-range contacts while increasing the heterogeneity of the conformational population. CEL also inhibited the αS aggregation, but it was not able to disassemble preexisting amyloid fibrils, thus proving that CEL found on LBs must be formed in a later event after aggregation.

Identifiers

PMID34122841
PMCPMC8157327
OpenAlexW3011158203

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.